Relenvatinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Relenvatinib, covering 2020-03-24 to 2020-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation [Phase 3]